Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Market Cap	1.21T +11.8%
Revenue (ttm)	1.69T +6.7%
Net Income	77.51B -28.9%
EPS	5,845.54 -29.0%
Shares Out	13.18M
PE Ratio	15.69
Forward PE	16.89
Dividend	1,100.00 (1.22%)
Ex-Dividend Date	Dec 29, 2025

Volume	15,155
Average Volume	34,229
Open	91,700
Previous Close	91,700
Day's Range	89,500 - 91,700
52-Week Range	70,900 - 106,800
Beta	0.37
RSI	57.34
Earnings Date	Apr 28, 2026

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 2,253
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 185750

Financial Performance

In 2025, KRX:185750's revenue was 1.69 trillion, an increase of 6.68% compared to the previous year's 1.59 trillion. Earnings were 77.51 billion, a decrease of -28.94%.